According to the Securities Times, on May 23, at a group performance briefing, Sano Healthcare said that the “self-inflating intracranial drug coating stent system” independently developed by Sano Shenchang has obtained special review and approval for innovative medical devices by the Medical Device Technology Evaluation Center of the State Drug Administration and is currently in the registration process.
赛诺医疗自膨式颅内药物涂层支架目前正处于注册过程中
Sano Healthcare's self-inflating intracranial drug-coated stents are currently in the process of registration
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.